Literature DB >> 29512223

Pseudomonas aeruginosa infection alters the macrophage phenotype switching process during wound healing in diabetic mice.

Sinuo Chen1, Renren Li1, Chun Cheng1, Jing-Ying Xu1, Caixia Jin1, Furong Gao1, Juan Wang1, Jieping Zhang1, Jingfa Zhang1, Hong Wang2, Lixia Lu1, Guo-Tong Xu1,3, Haibin Tian1.   

Abstract

Macrophages play critical roles in wound healing process. They switch from "classically activated" (M1) phenotype in the early inflammatory phase to "alternatively activated" (M2) phenotype in the later healing phase. However, the dynamic process of macrophage phenotype switching in diabetic wounds burdened with bacteria is unclear. In this report, Pseudomonas aeruginosa, frequently detected in diabetic foot ulcers, was inoculated into cutaneous wounds of db/db diabetic mice to mimic bacterium-infected diabetic wound healing. We observed that P. aeruginosa infection impaired diabetic wound healing and quickly promoted the expression of pro-inflammatory genes (M1 macrophage markers) tumor necrosis factor-α (tnf-α), interleukin-1β (il-1β) and il-6 in wounds. The expression of markers of M2 macrophages, including il-10, arginase-1, and ym1 were also upregulated. In addition, similar gene expression patterns were observed in macrophages isolated directly from wounds. Immunostaining showed that P. aeruginosa infection increased both the ratios of M1 and M2 macrophages in wounds compared with that in control groups, which was further confirmed by in vitro culturing macrophages with P. aeruginosa and skin fibroblast conditioned medium. However, the ratios of the expression levels of pro-inflammatory genes to anti-inflammatory gene il-10 was increased markedly in P. aeruginosa infected wounds and macrophages compared with that in control groups, and P. aeruginosa prolonged the presence of M1 macrophages in the wounds. These data demonstrated that P. aeruginosa in diabetic wounds activates a mixed M1/M2 macrophage phenotype with an excessive activation of M1 phenotype or relatively inadequate activation of M2 phenotype.
© 2018 International Federation for Cell Biology.

Entities:  

Keywords:  Pseudomonas aeruginosa; diabetic wound healing; macrophage; phenotype switching

Mesh:

Substances:

Year:  2018        PMID: 29512223     DOI: 10.1002/cbin.10955

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  6 in total

1.  Effects of Des-acyl Ghrelin on Insulin Sensitivity and Macrophage Polarization in Adipose Tissue.

Authors:  Fang Yuan; Qianqian Zhang; Haiyan Dong; Xinxin Xiang; Weizhen Zhang; Yi Zhang; Yin Li
Journal:  J Transl Int Med       Date:  2021-07-02

2.  The Role of TSC1 in the Macrophages Against Vibrio vulnificus Infection.

Authors:  Xian-Hui Huang; Yao Ma; Han Lou; Na Chen; Ting Zhang; Liu-Ying Wu; Yi-Ju Chen; Meng-Meng Zheng; Yong-Liang Lou; Dan-Li Xie
Journal:  Front Cell Infect Microbiol       Date:  2021-01-27       Impact factor: 5.293

3.  Nanofiber-mediated sequential photothermal antibacteria and macrophage polarization for healing MRSA-infected diabetic wounds.

Authors:  Zhou Xu; Bin Deng; Xuewen Wang; Jie Yu; Zhuobin Xu; Penggang Liu; Caihong Liu; Yuan Cai; Fei Wang; Rongling Zong; Zhiling Chen; Hua Xing; Gang Chen
Journal:  J Nanobiotechnology       Date:  2021-12-05       Impact factor: 10.435

Review 4.  Pyroptosis and inflammasomes in diabetic wound healing.

Authors:  Xingrui Mu; Xingqian Wu; Wenjie He; Ye Liu; Faming Wu; Xuqiang Nie
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-05       Impact factor: 6.055

Review 5.  Wound Healing Impairment in Type 2 Diabetes Model of Leptin-Deficient Mice-A Mechanistic Systematic Review.

Authors:  Albert Stachura; Ishani Khanna; Piotr Krysiak; Wiktor Paskal; Paweł Włodarski
Journal:  Int J Mol Sci       Date:  2022-08-03       Impact factor: 6.208

Review 6.  Macrophage Related Chronic Inflammation in Non-Healing Wounds.

Authors:  Meirong Li; Qian Hou; Lingzhi Zhong; Yali Zhao; Xiaobing Fu
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.